EMEA (Europe, Middle East and Africa) Pemetrexed Market Report 2018

January 2018 | 103 pages | ID: ECAAA9ED215EN
QYResearch

Abstracts

In this report, the EMEA Pemetrexed market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (Units), revenue (Million USD), market share and growth rate of Pemetrexed for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Pemetrexed market competition by top manufacturers/players, with Pemetrexed sales volume (Units), price (K USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Eli Lilly
• Abbott Healthcare
• Cadila Healthcare

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• 100mg
• 500mg

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Pleural Mesothelioma
• Non-small Cell Lung Cancer

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Pemetrexed Market Report 2017

1 PEMETREXED OVERVIEW

1.1 Product Overview and Scope of Pemetrexed
1.2 Classification of Pemetrexed
  1.2.1 EMEA Pemetrexed Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Pemetrexed Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 100mg
  1.2.4 500mg
1.3 EMEA Pemetrexed Market by Application/End Users
  1.3.1 EMEA Pemetrexed Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Pleural Mesothelioma
  1.3.3 Non-small Cell Lung Cancer
1.4 EMEA Pemetrexed Market by Region
  1.4.1 EMEA Pemetrexed Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Pemetrexed (2012-2022)
  1.5.1 EMEA Pemetrexed Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Pemetrexed Revenue and Growth Rate (2012-2022)

2 EMEA PEMETREXED COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Pemetrexed Market Competition by Players/Manufacturers
  2.1.1 EMEA Pemetrexed Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Pemetrexed Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Pemetrexed Sale Price by Players (2012-2017)
2.2 EMEA Pemetrexed (Volume and Value) by Type/Product Category
  2.2.1 EMEA Pemetrexed Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Pemetrexed Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Pemetrexed Sale Price by Type (2012-2017)
2.3 EMEA Pemetrexed (Volume) by Application
2.4 EMEA Pemetrexed (Volume and Value) by Region
  2.4.1 EMEA Pemetrexed Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Pemetrexed Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Pemetrexed Sales Price by Region (2012-2017)

3 EUROPE PEMETREXED (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Pemetrexed Sales and Value (2012-2017)
  3.1.1 Europe Pemetrexed Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Pemetrexed Revenue and Growth Rate (2012-2017)
3.2 Europe Pemetrexed Sales and Market Share by Type
3.3 Europe Pemetrexed Sales and Market Share by Application
3.4 Europe Pemetrexed Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Pemetrexed Sales Volume by Countries (2012-2017)
  3.4.2 Europe Pemetrexed Revenue by Countries (2012-2017)
  3.4.3 Germany Pemetrexed Sales and Growth Rate (2012-2017)
  3.4.4 France Pemetrexed Sales and Growth Rate (2012-2017)
  3.4.5 UK Pemetrexed Sales and Growth Rate (2012-2017)
  3.4.6 Russia Pemetrexed Sales and Growth Rate (2012-2017)
  3.4.7 Italy Pemetrexed Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Pemetrexed Sales and Growth Rate (2012-2017)

4 MIDDLE EAST PEMETREXED (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Pemetrexed Sales and Value (2012-2017)
  4.1.1 Middle East Pemetrexed Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Pemetrexed Revenue and Growth Rate (2012-2017)
4.2 Middle East Pemetrexed Sales and Market Share by Type
4.3 Middle East Pemetrexed Sales and Market Share by Application
4.4 Middle East Pemetrexed Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Pemetrexed Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Pemetrexed Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Pemetrexed Sales and Growth Rate (2012-2017)
  4.4.4 Israel Pemetrexed Sales and Growth Rate (2012-2017)
  4.4.5 UAE Pemetrexed Sales and Growth Rate (2012-2017)
  4.4.6 Iran Pemetrexed Sales and Growth Rate (2012-2017)

5 AFRICA PEMETREXED (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Pemetrexed Sales and Value (2012-2017)
  5.1.1 Africa Pemetrexed Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Pemetrexed Revenue and Growth Rate (2012-2017)
5.2 Africa Pemetrexed Sales and Market Share by Type
5.3 Africa Pemetrexed Sales and Market Share by Application
5.4 Africa Pemetrexed Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Pemetrexed Sales Volume by Countries (2012-2017)
  5.4.2 Africa Pemetrexed Revenue by Countries (2012-2017)
  5.4.3 South Africa Pemetrexed Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Pemetrexed Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Pemetrexed Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Pemetrexed Sales and Growth Rate (2012-2017)

6 EMEA PEMETREXED MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Eli Lilly
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Pemetrexed Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Eli Lilly Pemetrexed Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Abbott Healthcare
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Pemetrexed Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Abbott Healthcare Pemetrexed Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Cadila Healthcare
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Pemetrexed Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Cadila Healthcare Pemetrexed Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview

7 PEMETREXED MANUFACTURING COST ANALYSIS

7.1 Pemetrexed Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Pemetrexed

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Pemetrexed Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Pemetrexed Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA PEMETREXED MARKET FORECAST (2017-2022)

11.1 EMEA Pemetrexed Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Pemetrexed Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Pemetrexed Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Pemetrexed Price and Trend Forecast (2017-2022)
11.2 EMEA Pemetrexed Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Pemetrexed Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Pemetrexed Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Pemetrexed Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Pemetrexed Sales Forecast by Type (2017-2022)
11.7 EMEA Pemetrexed Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Pemetrexed
Figure EMEA Pemetrexed Sales Volume (Units) by Type (2012-2022)
Figure EMEA Pemetrexed Sales Volume Market Share by Type (Product Category) in 2016
Figure 100mg Product Picture
Figure 500mg Product Picture
Figure EMEA Pemetrexed Sales Volume (Units) by Application (2012-2022)
Figure EMEA Sales Market Share of Pemetrexed by Application in 2016
Figure Pleural Mesothelioma Examples
Table Key Downstream Customer in Pleural Mesothelioma
Figure Non-small Cell Lung Cancer Examples
Table Key Downstream Customer in Non-small Cell Lung Cancer
Figure EMEA Pemetrexed Market Size (Million USD) by Region (2012-2022)
Figure Europe Pemetrexed Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Pemetrexed Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Pemetrexed Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Pemetrexed Revenue (Million USD) Status and Forecast by Countries
Figure Africa Pemetrexed Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Pemetrexed Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Pemetrexed Sales Volume and Growth Rate (2012-2022)
Figure EMEA Pemetrexed Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Pemetrexed Market Major Players Product Sales Volume (Units) (2012-2017)
Table EMEA Pemetrexed Sales Volume (Units) of Major Players (2012-2017)
Table EMEA Pemetrexed Sales Share by Players (2012-2017)
Figure 2016 Pemetrexed Sales Share by Players
Figure 2017 Pemetrexed Sales Share by Players
Figure EMEA Pemetrexed Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Pemetrexed Revenue (Million USD) by Players (2012-2017)
Table EMEA Pemetrexed Revenue Share by Players (2012-2017)
Table 2016 EMEA Pemetrexed Revenue Share by Players
Table 2017 EMEA Pemetrexed Revenue Share by Players
Table EMEA Pemetrexed Sale Price (K USD/Unit) by Players (2012-2017)
Table EMEA Pemetrexed Sales (Units) and Market Share by Type (2012-2017)
Table EMEA Pemetrexed Sales Share by Type (2012-2017)
Figure Sales Market Share of Pemetrexed by Type (2012-2017)
Figure EMEA Pemetrexed Sales Market Share by Type (2012-2017)
Table EMEA Pemetrexed Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Pemetrexed Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Pemetrexed by Type in 2016
Table EMEA Pemetrexed Sale Price (K USD/Unit) by Type (2012-2017)
Table EMEA Pemetrexed Sales (Units) and Market Share by Application (2012-2017)
Table EMEA Pemetrexed Sales Share by Application (2012-2017)
Figure Sales Market Share of Pemetrexed by Application (2012-2017)
Figure EMEA Pemetrexed Sales Market Share by Application in 2016
Table EMEA Pemetrexed Sales (Units) and Market Share by Region (2012-2017)
Table EMEA Pemetrexed Sales Share by Region (2012-2017)
Figure Sales Market Share of Pemetrexed by Region (2012-2017)
Figure EMEA Pemetrexed Sales Market Share in 2016
Table EMEA Pemetrexed Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Pemetrexed Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Pemetrexed by Region (2012-2017)
Figure EMEA Pemetrexed Revenue Market Share Regions in 2016
Table EMEA Pemetrexed Sales Price (K USD/Unit) by Region (2012-2017)
Figure Europe Pemetrexed Sales (Units) and Growth Rate (2012-2017)
Figure Europe Pemetrexed Revenue and Growth Rate (2012-2017)
Table Europe Pemetrexed Sales (Units) by Type (2012-2017)
Table Europe Pemetrexed Market Share by Type (2012-2017)
Figure Europe Pemetrexed Market Share by Type in 2016
Table Europe Pemetrexed Sales (Units) by Application (2012-2017)
Table Europe Pemetrexed Market Share by Application (2012-2017)
Figure Europe Pemetrexed Market Share by Application in 2016
Table Europe Pemetrexed Sales (Units) by Countries (2012-2017)
Table Europe Pemetrexed Sales Market Share by Countries (2012-2017)
Figure Europe Pemetrexed Sales Market Share by Countries (2012-2017)
Figure Europe Pemetrexed Sales Market Share by Countries in 2016
Table Europe Pemetrexed Revenue (Million USD) by Countries (2012-2017)
Table Europe Pemetrexed Revenue Market Share by Countries (2012-2017)
Figure Europe Pemetrexed Revenue Market Share by Countries (2012-2017)
Figure Europe Pemetrexed Revenue Market Share by Countries in 2016
Figure Germany Pemetrexed Sales (Units) and Growth Rate (2012-2017)
Figure France Pemetrexed Sales (Units) and Growth Rate (2012-2017)
Figure UK Pemetrexed Sales (Units) and Growth Rate (2012-2017)
Figure Russia Pemetrexed Sales (Units) and Growth Rate (2012-2017)
Figure Italy Pemetrexed Sales (Units) and Growth Rate (2012-2017)
Figure Benelux Pemetrexed Sales (Units) and Growth Rate (2012-2017)
Figure Middle East Pemetrexed Sales (Units) and Growth Rate (2012-2017)
Figure Middle East Pemetrexed Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Pemetrexed Sales (Units) by Type (2012-2017)
Table Middle East Pemetrexed Market Share by Type (2012-2017)
Figure Middle East Pemetrexed Market Share by Type (2012-2017)
Table Middle East Pemetrexed Sales (Units) by Applications (2012-2017)
Table Middle East Pemetrexed Market Share by Applications (2012-2017)
Figure Middle East Pemetrexed Sales Market Share by Application in 2016
Table Middle East Pemetrexed Sales Volume (Units) by Countries (2012-2017)
Table Middle East Pemetrexed Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Pemetrexed Sales Volume Market Share by Countries in 2016
Table Middle East Pemetrexed Revenue (Million USD) by Countries (2012-2017)
Table Middle East Pemetrexed Revenue Market Share by Countries (2012-2017)
Figure Middle East Pemetrexed Revenue Market Share by Countries (2012-2017)
Figure Middle East Pemetrexed Revenue Market Share by Countries in 2016
Figure Saudi Arabia Pemetrexed Sales (Units) and Growth Rate (2012-2017)
Figure Israel Pemetrexed Sales (Units) and Growth Rate (2012-2017)
Figure UAE Pemetrexed Sales (Units) and Growth Rate (2012-2017)
Figure Iran Pemetrexed Sales (Units) and Growth Rate (2012-2017)
Figure Africa Pemetrexed Sales (Units) and Growth Rate (2012-2017)
Figure Africa Pemetrexed Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Pemetrexed Sales (Units) by Type (2012-2017)
Table Africa Pemetrexed Sales Market Share by Type (2012-2017)
Figure Africa Pemetrexed Sales Market Share by Type (2012-2017)
Figure Africa Pemetrexed Sales Market Share by Type in 2016
Table Africa Pemetrexed Sales (Units) by Application (2012-2017)
Table Africa Pemetrexed Sales Market Share by Application (2012-2017)
Figure Africa Pemetrexed Sales Market Share by Application (2012-2017)
Table Africa Pemetrexed Sales Volume (Units) by Countries (2012-2017)
Table Africa Pemetrexed Sales Market Share by Countries (2012-2017)
Figure Africa Pemetrexed Sales Market Share by Countries (2012-2017)
Figure Africa Pemetrexed Sales Market Share by Countries in 2016
Table Africa Pemetrexed Revenue (Million USD) by Countries (2012-2017)
Table Africa Pemetrexed Revenue Market Share by Countries (2012-2017)
Figure Africa Pemetrexed Revenue Market Share by Countries (2012-2017)
Figure Africa Pemetrexed Revenue Market Share by Countries in 2016
Figure South Africa Pemetrexed Sales (Units) and Growth Rate (2012-2017)
Figure Nigeria Pemetrexed Sales (Units) and Growth Rate (2012-2017)
Figure Egypt Pemetrexed Sales (Units) and Growth Rate (2012-2017)
Figure Algeria Pemetrexed Sales (Units) and Growth Rate (2012-2017)
Table Eli Lilly Pemetrexed Basic Information List
Table Eli Lilly Pemetrexed Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Eli Lilly Pemetrexed Sales (Units) and Growth Rate (2012-2017)
Figure Eli Lilly Pemetrexed Sales Market Share in EMEA (2012-2017)
Figure Eli Lilly Pemetrexed Revenue Market Share in EMEA (2012-2017)
Table Abbott Healthcare Pemetrexed Basic Information List
Table Abbott Healthcare Pemetrexed Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Abbott Healthcare Pemetrexed Sales (Units) and Growth Rate (2012-2017)
Figure Abbott Healthcare Pemetrexed Sales Market Share in EMEA (2012-2017)
Figure Abbott Healthcare Pemetrexed Revenue Market Share in EMEA (2012-2017)
Table Cadila Healthcare Pemetrexed Basic Information List
Table Cadila Healthcare Pemetrexed Sales (Units), Revenue (Million USD), Price (K USD/Unit) and Gross Margin (2012-2017)
Figure Cadila Healthcare Pemetrexed Sales (Units) and Growth Rate (2012-2017)
Figure Cadila Healthcare Pemetrexed Sales Market Share in EMEA (2012-2017)
Figure Cadila Healthcare Pemetrexed Revenue Market Share in EMEA (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Pemetrexed
Figure Manufacturing Process Analysis of Pemetrexed
Figure Pemetrexed Industrial Chain Analysis
Table Raw Materials Sources of Pemetrexed Major Manufacturers in 2016
Table Major Buyers of Pemetrexed
Table Distributors/Traders List
Figure EMEA Pemetrexed Sales (Units) and Growth Rate Forecast (2017-2022)
Figure EMEA Pemetrexed Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Pemetrexed Price (K USD/Unit) and Trend Forecast (2017-2022)
Table EMEA Pemetrexed Sales (Units) Forecast by Region (2017-2022)
Figure EMEA Pemetrexed Sales Market Share Forecast by Region (2017-2022)
Table EMEA Pemetrexed Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Pemetrexed Revenue Market Share Forecast by Region (2017-2022)
Table Europe Pemetrexed Sales (Units) Forecast by Countries (2017-2022)
Figure Europe Pemetrexed Sales Market Share Forecast by Countries (2017-2022)
Table Europe Pemetrexed Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Pemetrexed Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Pemetrexed Sales (Units) Forecast by Countries (2017-2022)
Figure Middle East Pemetrexed Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Pemetrexed Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Pemetrexed Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Pemetrexed Sales (Units) Forecast by Countries (2017-2022)
Figure Africa Pemetrexed Sales Market Share Forecast by Countries (2017-2022)
Table Africa Pemetrexed Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Pemetrexed Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Pemetrexed Sales (Units) Forecast by Type (2017-2022)
Figure EMEA Pemetrexed Sales Market Share Forecast by Type (2017-2022)
Table EMEA Pemetrexed Sales (Units) Forecast by Application (2017-2022)
Figure EMEA Pemetrexed Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources